BRPI0915718A2 - peptídeos de direção crkl - Google Patents
peptídeos de direção crklInfo
- Publication number
- BRPI0915718A2 BRPI0915718A2 BRPI0915718A BRPI0915718A BRPI0915718A2 BR PI0915718 A2 BRPI0915718 A2 BR PI0915718A2 BR PI0915718 A BRPI0915718 A BR PI0915718A BR PI0915718 A BRPI0915718 A BR PI0915718A BR PI0915718 A2 BRPI0915718 A2 BR PI0915718A2
- Authority
- BR
- Brazil
- Prior art keywords
- crkl
- peptides
- steering
- steering peptides
- crkl steering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
- C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7442308P | 2008-06-20 | 2008-06-20 | |
PCT/US2009/048024 WO2009155556A2 (en) | 2008-06-20 | 2009-06-19 | Crkl targeting peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0915718A2 true BRPI0915718A2 (pt) | 2017-06-20 |
Family
ID=41434721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0915718A BRPI0915718A2 (pt) | 2008-06-20 | 2009-06-19 | peptídeos de direção crkl |
Country Status (14)
Country | Link |
---|---|
US (1) | US20110189095A1 (pt) |
EP (1) | EP2303913A4 (pt) |
JP (1) | JP2011525491A (pt) |
CN (1) | CN102105487A (pt) |
BR (1) | BRPI0915718A2 (pt) |
CA (1) | CA2728763A1 (pt) |
CL (1) | CL2010001498A1 (pt) |
CO (1) | CO6331291A2 (pt) |
CR (1) | CR20110034A (pt) |
EC (1) | ECSP10010729A (pt) |
IL (1) | IL210053A0 (pt) |
MX (1) | MX2010014173A (pt) |
PE (1) | PE20110309A1 (pt) |
WO (1) | WO2009155556A2 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101870734B (zh) * | 2010-05-25 | 2012-06-20 | 北京大学 | 一种抑制新生血管生成的融合多肽及其编码基因与应用 |
CU23950B1 (es) * | 2011-03-21 | 2013-10-29 | Ct De Ingeniería Genética Y Biotecnología | Péptidos cíclicos con actividad antineoplásica y antiangiogénica |
CN105612173A (zh) * | 2013-07-25 | 2016-05-25 | 诺华股份有限公司 | 用于治疗心力衰竭的环状apelin衍生物 |
TW201536814A (zh) * | 2013-07-25 | 2015-10-01 | Novartis Ag | 用於治療心臟衰竭之合成環狀多肽 |
MX2016001021A (es) * | 2013-07-25 | 2016-08-03 | Novartis Ag | Bioconjugados de polipeptidos de apelina sinteticos. |
CN105612174A (zh) * | 2013-07-25 | 2016-05-25 | 诺华股份有限公司 | 用于治疗心力衰竭的二硫化物环状多肽 |
CN104250287B (zh) | 2013-09-11 | 2017-03-22 | 中山大学附属肿瘤医院 | 肿瘤靶向多肽及应用 |
EP3107998B1 (en) | 2014-01-27 | 2020-03-25 | The Children's Hospital of Philadelphia | Compositions and methods for treating autoimmune and inflammatory diseases |
CN108303539B (zh) * | 2018-01-31 | 2020-08-11 | 刘双萍 | 一种乳腺癌细胞检测生物试剂及应用 |
CN110025577B (zh) * | 2019-03-19 | 2021-09-07 | 广东药科大学 | 一种多肽药物口服靶向系统M27-39@FA-MCNs复合体及其制备方法和应用 |
CN109908369B (zh) * | 2019-04-28 | 2022-02-11 | 复旦大学附属金山医院 | 一种新的环状RNA circCRKL在前列腺癌治疗中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5667981A (en) * | 1994-05-13 | 1997-09-16 | Childrens Hospital Of Los Angeles | Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein |
US7309692B1 (en) * | 1996-07-08 | 2007-12-18 | Board Of Regents, The University Of Texas System | Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1 |
US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
CA2496938A1 (en) * | 2002-08-30 | 2004-03-11 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
AU2005307789A1 (en) * | 2004-11-16 | 2006-05-26 | Avidia Research Institute | Protein scaffolds and uses thereof |
WO2009091518A2 (en) * | 2008-01-15 | 2009-07-23 | Monsanto Technology, Llc | Isolated novel nucleic acid and protein molecules from corn and methods of using those molecules to generate transgenic plant with enhanced agronomic traits |
-
2009
- 2009-06-19 CN CN2009801292540A patent/CN102105487A/zh active Pending
- 2009-06-19 BR BRPI0915718A patent/BRPI0915718A2/pt not_active IP Right Cessation
- 2009-06-19 US US13/000,231 patent/US20110189095A1/en not_active Abandoned
- 2009-06-19 MX MX2010014173A patent/MX2010014173A/es not_active Application Discontinuation
- 2009-06-19 PE PE2010001154A patent/PE20110309A1/es not_active Application Discontinuation
- 2009-06-19 CA CA2728763A patent/CA2728763A1/en not_active Abandoned
- 2009-06-19 WO PCT/US2009/048024 patent/WO2009155556A2/en active Application Filing
- 2009-06-19 EP EP09767865.0A patent/EP2303913A4/en not_active Withdrawn
- 2009-06-19 JP JP2011514861A patent/JP2011525491A/ja not_active Withdrawn
-
2010
- 2010-12-16 IL IL210053A patent/IL210053A0/en unknown
- 2010-12-20 CL CL2010001498A patent/CL2010001498A1/es unknown
- 2010-12-20 CO CO10159776A patent/CO6331291A2/es not_active Application Discontinuation
- 2010-12-29 EC EC2010010729A patent/ECSP10010729A/es unknown
-
2011
- 2011-01-20 CR CR20110034A patent/CR20110034A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20110189095A1 (en) | 2011-08-04 |
EP2303913A4 (en) | 2013-07-24 |
EP2303913A2 (en) | 2011-04-06 |
CA2728763A1 (en) | 2009-12-23 |
CN102105487A (zh) | 2011-06-22 |
CL2010001498A1 (es) | 2011-05-20 |
MX2010014173A (es) | 2011-06-20 |
WO2009155556A3 (en) | 2010-04-08 |
CO6331291A2 (es) | 2011-10-20 |
JP2011525491A (ja) | 2011-09-22 |
WO2009155556A2 (en) | 2009-12-23 |
IL210053A0 (en) | 2011-02-28 |
PE20110309A1 (es) | 2011-06-19 |
CR20110034A (es) | 2011-06-24 |
ECSP10010729A (es) | 2011-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0915718A2 (pt) | peptídeos de direção crkl | |
DE602008000880D1 (de) | Lenksystem | |
DE602008002674D1 (de) | Lenksystem | |
DE602007012976D1 (de) | Lenksystem | |
DE602008000562D1 (de) | Fahrzeugrad | |
BRPI0811014A2 (pt) | Veículo | |
BRPI0815042A2 (pt) | Compostos de pirazol | |
DE602007002422D1 (de) | Fahrzeuglenkung | |
DK3118221T3 (da) | Proteiner | |
BRPI0812593A2 (pt) | sensor de posição angular | |
BRPI0919596A2 (pt) | veículo | |
DE602008001653D1 (de) | Lenksystem | |
BRPI0815935A2 (pt) | sensor de posição | |
DK2264676T3 (da) | Sensor | |
BRPI0809660A2 (pt) | Carrinho de criança | |
BRPI0809659A2 (pt) | Carrinho de criança | |
DE602008001297D1 (de) | Fahrzeugrad | |
DE602008005235D1 (de) | Elektrisches Lenksystem | |
BRPI0819415A2 (pt) | Sensor de posição | |
ATE547159T1 (de) | Fahrzeug | |
DE602008003149D1 (de) | Airbag-System | |
BRPI0906881A2 (pt) | Articulação de direção | |
BRPI0814763A2 (pt) | Peptídeos imunomoduladores | |
DE602008000034D1 (de) | Rollerartiges Fahrzeug | |
BR112012000704A2 (pt) | robô de direção |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |